Analysis of lamotrigine and its metabolites in human plasma and urine by micellar electrokinetic capillary chromatography
- 15 February 2005
- journal article
- research article
- Published by Wiley in Electrophoresis
- Vol. 26 (4-5) , 935-942
Abstract
A reliable micellar electrokinetic capillary chromatographic method was developed and validated for the determination of lamotrigine and its metabolites in human plasma and urine. The variation of different parameters, such as pH of the background electrolyte (BGE) and Sodium dodecyl sulfate (SDS) concentration, were evaluated in order to find optimal conditions. Best separation of the analytes was achieved using a BGE composed of 10 mM borate and 50 mM SDS, pH 9.5; melatonin was selected as the internal standard. Isolation of lamotrigine and its metabolites from plasma and urine was accomplished with an original solid‐phase extraction procedure using hydrophilic‐lypophilic balance cartridges. Good absolute recovery data and satisfactory precision values were obtained. The calibration plots for lamotrigine and its metabolites were linear over the 1–20 μg/mL concentration range. Sensitivity was satisfactory; the limits of detection and quantitation of lamotrigine were 500 ng/mL and 1 μg/mL, respectively. The application of the method to real plasma samples from epileptic patients under therapy with lamotrigine gave good results in terms of accuracy and selectivity, and in agreement with those obtained with an high‐performance liquid chromatography (HPLC) method.*Keywords
This publication has 27 references indexed in Scilit:
- New Antiepileptic DrugsAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1999
- The Influence of Dosage, Age, and Comedication on Steady State Plasma Lamotrigine Concentrations in Epileptic ChildrenTherapeutic Drug Monitoring, 1997
- Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: retrospective analysis of routine monitoring dataBritish Journal of Clinical Pharmacology, 1997
- Update on the Mechanism of Action of Antiepileptic DrugsEpilepsia, 1996
- Concentration‐Effect and Concentration‐Toxicity Relations with Lamotrigine: A Prospective StudyEpilepsia, 1996
- Measurement of Lamotrigine Under Conditions Measuring Phenobarbitone, Phenytoin, and Carbamazepine Using Reversed-Phase High-Performance Liquid Chromatography at Dual WavelengthsTherapeutic Drug Monitoring, 1994
- Lamotrigine Clinical PharmacokineticsClinical Pharmacokinetics, 1993
- A Liquid Chromatographic Assay Using a High-Speed Column for the Determination of Lamotrigine, a New Antiepileptic Drug, in Human PlasmaTherapeutic Drug Monitoring, 1992
- Analysis of lamotrigine and lamotrigine 2-N-glucuronide in guinea pig blood and urine by reserved-phase ion-pairing liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1991
- Performance analysis of a reversed-phase liquid chromatographic assay of lamotrigine in plasma using solvent-demixing extractionJournal of Chromatography B: Biomedical Sciences and Applications, 1991